private:transcriptic
|
2880319
|
Mar 22nd, 2021 12:00AM
|
Transcriptic
|
2.2K
|
9.00
|
Open
|
Biotechnology
|
Mar 22nd, 2021 05:41AM
|
Mar 22nd, 2021 05:41AM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 21st, 2021 12:00AM
|
Transcriptic
|
2.2K
|
9.00
|
Open
|
Biotechnology
|
Mar 21st, 2021 03:37PM
|
Mar 21st, 2021 03:37PM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 20th, 2021 12:00AM
|
Transcriptic
|
2.2K
|
9.00
|
Open
|
Biotechnology
|
Mar 20th, 2021 03:33AM
|
Mar 20th, 2021 03:33AM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 19th, 2021 12:00AM
|
Transcriptic
|
2.2K
|
9.00
|
Open
|
Biotechnology
|
Mar 19th, 2021 11:25AM
|
Mar 19th, 2021 11:25AM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 18th, 2021 12:00AM
|
Transcriptic
|
2.2K
|
9.00
|
Open
|
Biotechnology
|
Mar 18th, 2021 03:12AM
|
Mar 18th, 2021 06:17PM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 17th, 2021 12:00AM
|
Transcriptic
|
2.1K
|
9.00
|
Open
|
Biotechnology
|
Mar 17th, 2021 03:11PM
|
Mar 17th, 2021 03:11PM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 16th, 2021 12:00AM
|
Transcriptic
|
2.1K
|
9.00
|
Open
|
Biotechnology
|
Mar 16th, 2021 02:52AM
|
Mar 16th, 2021 02:52AM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 15th, 2021 12:00AM
|
Transcriptic
|
2.1K
|
9.00
|
Open
|
Biotechnology
|
Mar 15th, 2021 04:45PM
|
Mar 15th, 2021 04:45PM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 14th, 2021 12:00AM
|
Transcriptic
|
2.1K
|
9.00
|
Open
|
Biotechnology
|
Mar 14th, 2021 06:21PM
|
Mar 14th, 2021 06:21PM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:transcriptic
|
2880319
|
Mar 13th, 2021 12:00AM
|
Transcriptic
|
2.1K
|
9.00
|
Open
|
Biotechnology
|
Mar 13th, 2021 05:14PM
|
Mar 13th, 2021 05:14PM
|
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world.
Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface.
Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
|
Open
|
Biomarkers, Lab Automation, Drug Discovery, Assays, qPCR, MSD, ELISA, Robotics, IoT, Biotech, synthetic biology
|
Open
|
3565 Haven Avenue, Suite 3
|
Menlo Park
|
CA
|
US
|
94025
|
|
Transcriptic
|
Health Care
|
Pharmaceuticals & Biotechnology
|